We only have this paper's title and publication details.
Read it at the sourcehas been proposed as a modifier of disease risk in FTLD-TDP, particularly in
No takes yet. Share an insight, caveat, or question.
Vandebergh et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: